Biotech · Private company
Schering-Plough
Track this companyFree. Adds Schering-Plough to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With ProgeriaPHASE2 · UNKNOWN · started Aug 1, 2009ClinicalTrials.gov NCT00916747 · fetched Nov 12, 2026
- Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk MelanomaPHASE2 · ACTIVE_NOT_RECRUITING · started May 9, 2008ClinicalTrials.gov NCT00539591 · fetched Nov 12, 2026
- Phase I Dose-Escalation Study Of Azacitidine In Combination With TemozolomidePHASE1 · COMPLETED · started Oct 1, 2007ClinicalTrials.gov NCT00629343 · fetched Nov 12, 2026
- Phase II Trial of Extended-Dosing Temozolomide in Patients With MelanomaPHASE2 · COMPLETED · started Jan 1, 2005ClinicalTrials.gov NCT00591370 · fetched Nov 12, 2026
- Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic OligodendrogliomaPHASE2 · COMPLETED · started Sep 1, 2002ClinicalTrials.gov NCT00588523 · fetched Nov 12, 2026
- CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's LymphomaNA · COMPLETED · started May 23, 2001ClinicalTrials.gov NCT00574730 · fetched Nov 12, 2026